As of 2024-12-12, the Relative Valuation of Biosergen AB (BIOSGN.ST) is (3.31) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.66 SEK, the upside of Biosergen AB based on Relative Valuation is -604.2%.
The range of the Relative Valuation is (2.95) - (3.51) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 18.4x | 15.4x |
| Forward P/E multiples | 15.5x - 23.2x | 19.4x |
| Fair Price | (2.95) - (3.51) | (3.31) |
| Upside | -549.8% - -635.3% | -604.2% |
| Date | P/E |
| 2024-11-20 | -3.35 |
| 2024-11-19 | -3.42 |
| 2024-11-18 | -3.44 |
| 2024-11-15 | -3.45 |
| 2024-11-14 | -3.45 |
| 2024-11-13 | -3.32 |
| 2024-11-12 | -3.41 |
| 2024-11-11 | -3.65 |
| 2024-11-08 | -3.84 |
| 2024-11-07 | -3.66 |
| 2024-11-06 | -3.72 |
| 2024-11-05 | -3.80 |
| 2024-11-04 | -3.94 |
| 2024-11-01 | -3.76 |
| 2024-10-31 | -3.79 |
| 2024-10-30 | -3.88 |
| 2024-10-29 | -4.10 |
| 2024-10-28 | -4.15 |
| 2024-10-25 | -3.69 |
| 2024-10-24 | -3.64 |
| 2024-10-23 | -3.67 |
| 2024-10-22 | -4.01 |
| 2024-10-21 | -4.02 |
| 2024-10-18 | -5.17 |
| 2024-10-17 | -4.57 |
| 2024-10-16 | -3.32 |
| 2024-10-15 | -2.98 |
| 2024-10-14 | -2.40 |
| 2024-10-11 | -2.11 |
| 2024-10-10 | -2.09 |
| 2024-10-09 | -2.23 |
| 2024-10-08 | -2.46 |
| 2024-10-07 | -2.62 |
| 2024-10-04 | -2.58 |
| 2024-10-03 | -2.81 |
| 2024-10-02 | -2.89 |
| 2024-10-01 | -3.10 |
| 2024-09-30 | -3.19 |
| 2024-09-27 | -3.01 |
| 2024-09-26 | -3.25 |
| 2024-09-25 | -3.41 |
| 2024-09-24 | -3.35 |
| 2024-09-23 | -3.30 |
| 2024-09-20 | -3.65 |
| 2024-09-19 | -3.63 |
| 2024-09-18 | -3.54 |
| 2024-09-17 | -3.55 |
| 2024-09-16 | -3.63 |
| 2024-09-13 | -3.72 |
| 2024-09-12 | -3.68 |